Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Total revenue	$ 43,215	$ 41,861
Total cost of revenue	33,714	28,347
Gross profit	9,501	13,514
Operating expenses:
Research and development	8,538	6,422
Sales, general, and administrative	7,700	8,144
Total operating expenses	16,238	14,566
Loss from operations	(6,737)	(1,052)
Other income (expense):
Interest income, net	283	750
Other income (expense), net	(116)	820
Income (loss) before income taxes	(6,570)	518
Income tax expense	905	1,753
Net loss	$ (7,475)	$ (1,235)
Net income (loss) per share, basic (in dollars per share)	$ (0.20)	$ (0.03)
Net income (loss) per share, diluted (in dollars per share)	$ (0.20)	$ (0.03)
Shares used in per share calculations:
Basic (in shares)	37,846	36,694
Diluted (in shares)	37,846	36,694
Products
Total revenue	$ 36,930	$ 41,861
Total cost of revenue	27,900	28,347
Development
Total revenue	6,285	0
Total cost of revenue	$ 5,814	$ 0